Cite
HARVARD Citation
Vincent, R. et al. (2020). A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?. Diabetes, obesity & metabolism. 22 (12), pp. 2227-2240. [Online].